Emanuele Guardalben

Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells

Elisabetta Cavalieri, Antonella Rigo, Massimiliano Bonifacio et al. · Journal of Translational Medicine · 2011 · 67 citations · Full text

In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics

Gian Matteo Rigolin, Elena Saccenti, Emanuele Guardalben et al. · British Journal of Haematology · 2018 · 43 citations · Full text

α-bisabolol Is an Effective Proapoptotic Agent against BCR-ABL+ Cells in Synergism with Imatinib and Nilotinib

Massimiliano Bonifacio, Antonella Rigo, Emanuele Guardalben et al. · PLoS ONE · 2012 · 25 citations · Full text

An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and <i>TP53</i> disruption as predictors of outcome and chemorefractoriness

Gian Matteo Rigolin, Luca Formigaro, Maurizio Cavallari et al. · Oncotarget · 2017 · 14 citations · Full text

EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia

Mario Tiribelli, Massimiliano Bonifacio, Elisabetta Calistri et al. · Leukemia Research · 2013 · 12 citations

Hematological Malignancy, Oncology, Eutos Score +12